Healthcare stocks fade as obesity-drug optimism fades

Healthcare companies fell sharply Monday as ebullience about a new class of weight control drugs subsided.

Previous post Two Warner Bros. Discovery directors resign over antitrust concerns
Next post Country Garden shares suspended from Hong Kong stock exchange